Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alcon Inc.

86.20
-2.9200-3.28%
Post-market: 86.200.00000.00%16:26 EDT
Volume:1.65M
Turnover:143.50M
Market Cap:42.73B
PE:38.31
High:87.72
Open:87.44
Low:86.07
Close:89.12
Loading ...

Stock Track | Alcon Shares Plummet 6.58% as Q1 Earnings Miss Expectations and 2025 Guidance Cut

Stock Track
·
14 May

Alcon AG reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Stock Track | Alcon Shares Plunge 5.22% After-Hours on Q1 Earnings Miss and Lowered 2025 Guidance

Stock Track
·
14 May

Alcon Q1 Core Earnings Decline, Sales Rise

MT Newswires Live
·
14 May

Alcon Q1 Adj. EPS $0.73 Misses $0.75 Estimate, Sales $2.45B Miss $2.51B Estimate

Benzinga
·
14 May

Press Release: Alcon Reports First-Quarter 2025 Results and Launches Transformational Change in Ophthalmic Surgery with Unity VCS

Dow Jones
·
14 May

Alcon AG expected to post earnings of 75 cents a share - Earnings Preview

Reuters
·
10 May

Alcon (ALC) Gets a Buy from RBC Capital

TIPRANKS
·
25 Apr

Alcidion Group Limited (ALC) Receives a Hold from RBC Capital

TIPRANKS
·
23 Apr

Investing in Alcidion Group (ASX:ALC) a year ago would have delivered you a 65% gain

Simply Wall St.
·
22 Apr

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108

GlobeNewswire
·
09 Apr

Here’s Why ClearBridge Large Cap Growth Strategy Sold Alcon (ALC)

Insider Monkey
·
08 Apr

Med-Tech Investors Seek 'Safe Havens' Amid Tariff Fears -- Market Talk

Dow Jones
·
08 Apr

When Will Alcidion Group Limited (ASX:ALC) Become Profitable?

Simply Wall St.
·
07 Apr

Alcon Publishes Agenda for 2025 Annual General Meeting

Business Wire
·
04 Apr

ALC Stock May Rise With the Introduction of PanOptix Pro in US

Zacks
·
03 Apr

Alcon Expands Leadership in IOL Innovation with Clareon PanOptix Pro, Delivering Best-in-Class Light Utilization and Less Light Scatter

Business Wire
·
02 Apr

UBS Sticks to Their Buy Rating for Alcon (ALC)

TIPRANKS
·
02 Apr

Alcon Is Maintained at Overweight by Keybanc

Dow Jones
·
31 Mar

3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space

Zacks
·
31 Mar